A. Broers

发表

Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality.

A. Nagler, J. Cornelissen, A. Shimoni, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

V. Kuenen-Boumeester, S. Henzen‐Logmans, S. Henzen‐Logmans, 2000, Blood.

Flt3 Ligand Expands Lymphoid Progenitors Prior to Recovery of Thymopoiesis and Accelerates T Cell Reconstitution after Bone Marrow Transplantation1

F. Staal, E. Wils, H. Spits, 2007, The Journal of Immunology.

Cell Reconstitution after Bone Prior to Recovery of Thymopoiesis and Flt 3 Ligand Expands Lymphoid Progenitors

F. Staal, E. Wils, H. Spits, 2007 .

Marrow Transplantation Accelerates T Cell Reconstitution after Bone Prior to Recovery of Thymopoiesis and Flt3 Ligand Expands Lymphoid Progenitors

F. Staal, E. Wils, H. Spits, 2007 .

Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance

B. van der Holt, C. Lamers, C. V. van Bergen, 2019, HemaSphere.

Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT

M. Robin, I. Yakoub-Agha, J. Byrne, 2022, American journal of hematology.

QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors

H. van der Sijs, T. van Gelder, N. D. de Groot, 2018, British journal of clinical pharmacology.

Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells

G Huls, E J Petersen, J. Janssen, 2015, Leukemia.

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study

H. Bax, M. Hellemons, R. Hoek, 2022, medRxiv.

Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation.

M. Jongen‐Lavrencic, G. Ossenkoppele, J. Cornelissen, 2020, Blood advances.

Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile

J. Janssen, G. Huls, C. de Haar, 2020, Bone Marrow Transplantation.

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

B. van der Holt, J. Cornelissen, M. Hazenberg, 2022, Blood advances.

Quantification of newly developed T cells in mice by real-time quantitative PCR of T-cell receptor rearrangement excision circles.

J. V. van Dongen, J. Meijerink, B. Löwenberg, 2002, Experimental hematology.

Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants.

B. van der Holt, H. Spits, B. Löwenberg, 2003, Blood.

Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience

J. Cornelissen, M. van der Klift, C. Klerk, 2017, PloS one.

Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients

B. van der Holt, E. Wils, J. Gratama, 2011, Haematologica.

IL-7-mediated protection against minor-antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells.

E. Wils, H. Spits, B. Löwenberg, 2007, Haematologica.

The management of critically ill patients with haematological malignancies.

D. J. Westerloo, D. van Westerloo, N. Blijlevens, 2017, The Netherlands journal of medicine.

Lymphocyte recovery following allogeneic stem cell transplantation: New possibilities for improvement

B. Löwenberg, J. Cornelissen, J. Gratama, 2002 .

Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors.

B. van der Holt, D. Deeren, J. Cornelissen, 2019, Blood.

Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT

P. Dreger, L. Arcaini, J. Drozd-Sokołowska, 2024, American journal of hematology.

A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib

J. Versmissen, T. van Gelder, J. Doorduijn, 2016, European Journal of Clinical Pharmacology.

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.

M. Heemskerk, N. Kootstra, B. Lissenberg-Witte, 2022, JAMA oncology.

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

M. Heemskerk, N. Kootstra, R. Sanders, 2022, Blood Advances.

Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study

J. Bourhis, M. Mohty, U. Salmenniemi, 2023, Bone Marrow Transplantation.

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study

M. Heemskerk, N. Kootstra, R. Sanders, 2023, eClinicalMedicine.

Guideline summary: Intensive care admission, treatment and discharge of critically ill haemato-oncological patients

D. J. Westerloo, N. Blijlevens, N. Kusadasi, 2017 .

Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies.

E. Tholouli, U. Salmenniemi, E. Forcade, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide.

M. Labopin, M. Mohty, A. Bazarbachi, 2024, Leukemia.

PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT

J. Pérez-Simón, I. Sakellari, P. Matteucci, 2024, Blood advances.